Nuvalent, Inc.
Industry: Life Sciences ・ $NUVL on Nasdaq
Insider Sale
+$1,005,000
-23.09%
Shares
Shares Volume: 10,000 Shares
Average Share Price: $100.5
INSIDER
Balcom Alexandra
Chief Financial Officer (Officer)
reported on Oct 2 2024
traded on Sep 30 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 33,300 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,229,975 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 46 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $2,622,966.47 |
| COMPANY PREVIOUS TRADES |